This is because clinical trials have not been long enough to assess pancreatic cancer risk, and the risk may still be present
Borror A, Zieff G, Battaglini C, Stoner L (2018) The effects of postprandial exercise on glucose control in individuals with type 2 diabetes: a systematic review
This review also explores the implications of the answers to these questions for the use of GLP1 receptor agonists as antiobesity drugs
Semaglutide (Ozempic, Wegovy, compounded) Semaglutide has the longest half-life among commonly used GLP-1 medications at approximately seven days
doi: 10.1016/S0140-6736(23)01291-6 82 AmberyPParkerVEStumvollMPoschMGHeiseTPlum-MoerschelLet al
Factors such as BMI, medical history, current medications, and overall health goals all play a role in deciding if a lower-dose approach is safe and effective